Spotlight
Clinical Role
Clinical
Supplement Spotlight
CE
Subscribe
Press Release
Article
Camber Pharmaceuticals Launches Lurasidone Hydrochloride Tablets
Key Takeaways
- Lurasidone Hydrochloride Tablets treat schizophrenia in adults and adolescents aged 13 to 17 years.
- They address depressive episodes in Bipolar I Disorder for adults and pediatric patients aged 10 to 17.
Camber Pharmaceuticals is excited to announce the addition of Lurasidone Hydrochloride Tablets.
Lurasidone Hydrochloride Tablets are an atypical antipsychotic indicated for the treatment of:
- Schizophrenia in adults and adolescents (13 to 17 years)
- Depressive episode associated with Bipolar I Disorder (bipolar depression) in adults and pediatric patients (10 to 17 years) as monotherapy
- Depressive episode associated with Bipolar I Disorder (bipolar depression) in adults as adjunctive therapy with lithium or valproate
Lurasidone Hydrochloride Tablets in 20 mg, 40 mg, 60 mg, 80 mg, 120 mg strengths are available in 30-count bottles.
To find out more information on Lurasidone Hydrochloride Tablets, please visit: www.camberpharma.com/lurasidone
Related Videos
Related Content
